157 related articles for article (PubMed ID: 33403690)
1. The mutational landscape and prognostic indicators of pseudomyxoma peritonei originating from the ovary.
Wang B; Yao J; Ma R; Liu D; Lu Y; Shi G; An L; Xia A; Chen F; Pang S; Zhai X; Liu G; Chen S; Xu M; Song L; Xu H
Int J Cancer; 2021 Apr; 148(8):2036-2047. PubMed ID: 33403690
[TBL] [Abstract][Full Text] [Related]
2. Molecular profiles of high-grade and low-grade pseudomyxoma peritonei.
Noguchi R; Yano H; Gohda Y; Suda R; Igari T; Ohta Y; Yamashita N; Yamaguchi K; Terakado Y; Ikenoue T; Furukawa Y
Cancer Med; 2015 Dec; 4(12):1809-16. PubMed ID: 26475379
[TBL] [Abstract][Full Text] [Related]
3. Kras mutations and p53 overexpression in pseudomyxoma peritonei: association with phenotype and prognosis.
Shetty S; Thomas P; Ramanan B; Sharma P; Govindarajan V; Loggie B
J Surg Res; 2013 Mar; 180(1):97-103. PubMed ID: 23199549
[TBL] [Abstract][Full Text] [Related]
4. Appendix-derived Pseudomyxoma Peritonei (PMP): Molecular Profiling Toward Treatment of a Rare Malignancy.
Gleeson EM; Feldman R; Mapow BL; Mackovick LT; Ward KM; Morano WF; Rubin RR; Bowne WB
Am J Clin Oncol; 2018 Aug; 41(8):777-783. PubMed ID: 28263231
[TBL] [Abstract][Full Text] [Related]
5. Analysis of Mutation and Loss of Heterozygosity by Whole-Exome Sequencing Yields Insights into Pseudomyxoma Peritonei.
Pengelly RJ; Rowaiye B; Pickard K; Moran B; Dayal S; Tapper W; Mirnezami A; Cecil T; Mohamed F; Carr N; Ennis S
J Mol Diagn; 2018 Sep; 20(5):635-642. PubMed ID: 29936255
[TBL] [Abstract][Full Text] [Related]
6. Whole-Exome Sequencing Identifies Mutation Profile and Mutation Signature-Based Clustering Associated with Prognosis in Appendiceal Pseudomyxoma Peritonei.
Lin YL; Zhu JQ; Ma RQ; Meng W; Wang ZY; Li XB; Ma R; Wu HL; Xu HB; Gao Y; Li Y
Mol Cancer Res; 2024 Jan; 22(1):70-81. PubMed ID: 37768171
[TBL] [Abstract][Full Text] [Related]
7. Histological origin of pseudomyxoma peritonei in Chinese women: clinicopathology and immunohistochemistry.
Guo AT; Song X; Wei LX; Zhao P
World J Gastroenterol; 2011 Aug; 17(30):3531-7. PubMed ID: 21941421
[TBL] [Abstract][Full Text] [Related]
8. Molecular profiling of appendiceal epithelial tumors using massively parallel sequencing to identify somatic mutations.
Liu X; Mody K; de Abreu FB; Pipas JM; Peterson JD; Gallagher TL; Suriawinata AA; Ripple GH; Hourdequin KC; Smith KD; Barth RJ; Colacchio TA; Tsapakos MJ; Zaki BI; Gardner TB; Gordon SR; Amos CI; Wells WA; Tsongalis GJ
Clin Chem; 2014 Jul; 60(7):1004-11. PubMed ID: 24821835
[TBL] [Abstract][Full Text] [Related]
9. Pathological prognostic factors of pseudomyxoma peritonei: comprehensive clinicopathological analysis of 155 cases.
Yan F; Lin Y; Zhou Q; Chang H; Li Y
Hum Pathol; 2020 Mar; 97():9-18. PubMed ID: 31926211
[TBL] [Abstract][Full Text] [Related]
10. Genomic profile of pseudomyxoma peritonei analyzed using next-generation sequencing and immunohistochemistry.
Nummela P; Saarinen L; Thiel A; Järvinen P; Lehtonen R; Lepistö A; Järvinen H; Aaltonen LA; Hautaniemi S; Ristimäki A
Int J Cancer; 2015 Mar; 136(5):E282-9. PubMed ID: 25274248
[TBL] [Abstract][Full Text] [Related]
11. [Clinical evaluation of tumor-stroma ratio in pseudomyxoma peritonei from the appendix].
Ma R; Li XB; Yan FC; Lin YL; Li Y
Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Apr; 52(2):240-246. PubMed ID: 32306005
[TBL] [Abstract][Full Text] [Related]
12. [Prognostic value of clinical and pathological characteristics in 48 women with pseudomyxoma peritonei].
Lu YY; Guo AT; Liu AJ; Shi HY
Zhonghua Fu Chan Ke Za Zhi; 2013 Aug; 48(8):595-601. PubMed ID: 24199925
[TBL] [Abstract][Full Text] [Related]
13. Molecular genetic analysis of appendiceal mucinous adenomas in identical twins, including one with pseudomyxoma peritonei.
Shih IM; Yan H; Speyrer D; Shmookler BM; Sugarbaker PH; Ronnett BM
Am J Surg Pathol; 2001 Aug; 25(8):1095-9. PubMed ID: 11474297
[TBL] [Abstract][Full Text] [Related]
14. GNAS mutations as prognostic biomarker in patients with relapsed peritoneal pseudomyxoma receiving metronomic capecitabine and bevacizumab: a clinical and translational study.
Pietrantonio F; Berenato R; Maggi C; Caporale M; Milione M; Perrone F; Tamborini E; Baratti D; Kusamura S; Mariani L; Niger M; Mennitto A; Gloghini A; Bossi I; Settanni G; Busico A; Bagnoli PF; Di Bartolomeo M; Deraco M; de Braud F
J Transl Med; 2016 May; 14(1):125. PubMed ID: 27154293
[TBL] [Abstract][Full Text] [Related]
15. Serum and ascites tumor markers in the diagnostic and prognostic prediction for appendiceal pseudomyxoma peritonei.
Wang B; Ma R; Rao B; Xu H
BMC Cancer; 2023 Jan; 23(1):90. PubMed ID: 36703100
[TBL] [Abstract][Full Text] [Related]
16. Impact of a modified peritoneal cancer index using FDG-PET/CT (PET-PCI) in predicting tumor grade and progression-free survival in patients with pseudomyxoma peritonei.
Hotta M; Minamimoto R; Gohda Y; Igari T; Yano H
Eur Radiol; 2019 Oct; 29(10):5709-5716. PubMed ID: 30874878
[TBL] [Abstract][Full Text] [Related]
17. The genetic profile and molecular subtypes of human pseudomyxoma peritonei and appendiceal mucinous neoplasms: a systematic review.
Murage NW; Ahmed NM; Underwood TJ; Walters ZS; Breininger SP
Cancer Metastasis Rev; 2023 Mar; 42(1):335-359. PubMed ID: 36723696
[TBL] [Abstract][Full Text] [Related]
18. Whole-exome sequencing identified the genetic origin of a mucinous neoplasm in a mature cystic teratoma.
Choi YJ; Lee SH; Kim MS; Jung SH; Hur SY; Chung YJ; Lee SH
Pathology; 2016 Jun; 48(4):372-6. PubMed ID: 27114374
[TBL] [Abstract][Full Text] [Related]
19. A nomogram prediction model of pseudomyxoma peritonei established based on new prognostic factors of HE stained pathological images analysis.
Ma R; Su YD; Yan FC; Lin YL; Gao Y; Li Y
Cancer Med; 2024 Mar; 13(6):e7101. PubMed ID: 38506243
[TBL] [Abstract][Full Text] [Related]
20. CDX-2 expression in pseudomyxoma peritonei: a clinicopathological study of 42 cases.
Nonaka D; Kusamura S; Baratti D; Casali P; Younan R; Deraco M
Histopathology; 2006 Oct; 49(4):381-7. PubMed ID: 16978201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
